Stay updated on Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.

Latest updates to the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record revision was updated from v3.6.2 to v3.6.3, signaling a minor metadata update to the ClinicalTrials.gov entry. This change reflects a version bump rather than any modification to the trial details.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the study record was published. This represents a minor update to the page metadata rather than a substantive change to the study details.SummaryDifference0.0%

- Check39 days agoChange DetectedA recruitment notice 'No longer looking for participants' was added, and new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were introduced to aid users. The Intervention/Treatment heading formatting was standardized (from 'Intervention / Treatment' to 'Intervention/Treatment'), and a Revision: v3.6.0 marker was added to replace the previous version.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page footer revision label was updated from v3.5.4 to v3.5.5, indicating a new software build; no user-facing content appears to be altered.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page content. This change affects only the page version metadata and does not alter the study information or details.SummaryDifference0.0%

- Check74 days agoChange DetectedTaoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333 in the locations list, updating the site entry to reflect a different administrative designation and postal code. The change clarifies the exact geographic location of the site.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs Sorafenib in Advanced HCC Clinical Trial page.